Amazon Fire TV Stick with...

Amgen's new migraine drug hits insurance hurdles

REUTERS: Amgen Inc's push to get patients on its new US$575 a month migraine drug before competition emerges in September is facing barriers from insurers. Bracing for a flood of costly prescription claims for the drug, Aimovig, large insurers such as Anthem Inc have set requirements for patients ...

from Latest News https://ift.tt/2NJhnlW

No comments:

Post a Comment

Pages